Dose Dense AB1-007 (Abraxane) in Adjuvant Chemotherapy for Breast Cancer: A Feasibility Study
Phase of Trial: Phase IV
Latest Information Update: 15 Feb 2013
At a glance
- Drugs Paclitaxel (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 01 Jun 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Oct 2006 New trial record.